Skip to Main Content

Paper Details

Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA) Study.
Arthritis Rheumatol
29
2022
Author NameAffiliation
Rishi J DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2